Shares of Pluri Inc. (NASDAQ:PLUR – Get Free Report) fell 2.8% during trading on Wednesday . The company traded as low as $4.33 and last traded at $4.45. 4,272 shares changed hands during trading, a decline of 77% from the average session volume of 18,389 shares. The stock had previously closed at $4.58.
Pluri Price Performance
The stock has a market capitalization of $24.74 million, a P/E ratio of -0.74 and a beta of 1.64. The business’s 50 day simple moving average is $4.90 and its two-hundred day simple moving average is $5.26. The company has a quick ratio of 5.90, a current ratio of 5.90 and a debt-to-equity ratio of 4.44.
Pluri Company Profile
Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.
Featured Stories
- Five stocks we like better than Pluri
- 3 Best Fintech Stocks for a Portfolio Boost
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Stock Sentiment Analysis: How it Works
- 2 Drone Stocks Surging from Increased Media Attention
- What is a Secondary Public Offering? What Investors Need to Know
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.
